阻膽堿劑 的英文怎麼說
中文拼音 [zǔdǎnjiǎnjì]
阻膽堿劑
英文
cholinolytic-
A non - depolarizing neuromuscular blocking drug ( e. g., vecuronium, atracurium, or pancuronium ) can be substituted for succinylcholine, but the onset of paralysis is delayed by about 60 seconds
可以用非去極化的神經肌肉阻滯劑（如維可羅寧、卡肌寧或潘可羅寧）代替琥珀膽堿，但麻醉的出現將延遲60秒鐘。Drug name diphenhydramine ， ethanolamine class, histamine receptor type 1 blocker. has significant anticholinergic and sedative properties that causes some degree of topical anesthesia by impairing the transmission of nerve impulses
藥名：苯海拉明，氨基乙醇，組織胺受體1型阻滯劑有顯著的抗膽堿能和鎮靜特性，通過阻礙神經沖動傳導引起某種程度的局部麻醉。Mechanism of glutamate - induced inhibition of pulmonary surfactant lipid synthesis ? mda receptor ( nmdar ) antagonist mk - 801 could reverse glutamate - induced inhibition of [ 3h ] - choline incorporation in lung explants ; ? he expression of nmdar1 subtype existed in alveolar type ii epithelial cells ; ? he effect of glu on pc synthesis required l - arginine in cultured lung explants, nos activity and no production were increased significantly in lung explants with glu treatment ; and mk - 801 and nos inhibitor l - nna could block the increase of nos activity and no production induced by glu ; l - nna also could reverse the inhibition of [ 3h ] - choline incorporation induced by glu ; ( 4 ) mda content increased and sod level decreased in cultured lung explants of glu treament groups, mk - 801 and l - nna could reverse these effects ; ( 3 ) mk - 801, l - nna could block the release of ldh induced by glu
谷氨酸對肺表面活性物質脂質合成抑制的機制研究nmda受體拮抗劑mk - 801能逆轉glu所致肺組織[ ~ 3h ] -膽堿摻入減少的效應；肺泡上皮細胞有nmda受體nmdar1亞單位的表達； glu對ps脂質合成的影響依賴l -精氨酸的存在， glu可使肺組織勻漿中nos活性、 no合成量升高； mk - 801 、 nos的抑制劑l - nna均可阻斷glu所致的這些效應； l - nna可逆轉glu所致肺組織[ ~ 3h ] -膽堿摻入減少的效應； glu可使肺組織勻漿中mda碩士學位論文中文摘要含量增高、 sod水平下降。 mk七0 、 l nna能阻斷q所致的這些效應； mk80 、 l nna還能阻斷gill誘導的ldh釋放增多的效應。
分享友人